Association of total medication burden with intensive and standard blood pressure control and clinical outcomes: A secondary analysis of SPRINT
Hypertension Jul 05, 2019
Derington CG, et al. - Given the potential link between total medication burden (antihypertensive and non-antihypertensive medications) and poor systolic blood pressure (SBP) control, researchers performed this secondary analysis of the Systolic Blood Pressure Intervention Trial to determine the link between baseline medication burden and clinical outcomes. They also looked for any differences in the impact of SBP intervention according to baseline medication burden. This study included participants (n=3,769) with high baseline medication burden (≥ 5 medications) and those (n=5,592) with low burden (< 5 medications). Participants were randomized to either intensive or standard SBP goal (below 120 or 140 mmHg, respectively). Findings revealed a minimum association of medication burden with adherence or satisfaction. Worse intensive SBP control and higher rates of cardiovascular disease events and serious adverse events were reported in relation to high baseline medication burden. Irrespective of medication burden, the relative benefits and risks of intensive SBP goals were similar.
Sign-up to continue reading. It is free & takes less than 2 mins
45 lakhs+ doctors trust M3 globally
Free & unlimited access to original articles and quizzes
Secure: we never sell your data
Sign up with M3 India to try daily quizzes and take part in competitionsTry M3 India / Log In
Why join our Market Research Panel?
- 10K+ Doctors participated in 40+ Indian and Global studies in 2018
- Average honorarium per study was Rs. 1,600 and total honoraria as high as Rs. 12,000 was earned by a Doctor